Prognostic significance of left atrial diameter to left ventricular diastolic diameter ratio in patients with heart failure with preserved ejection fraction
Efficacy and safety of sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction according to background MRA therapy: a pooled analysis of PARAGLIDE-HF and PARAGON-HF
Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: analysis of safety outcomes of the REBALANCE-HF randomized trial